ArQule, Inc. (NASDAQ:ARQL)
CAPS Rating:
A clinical-stage biotechnology company, engaged in the research and development of cancer therapeutics. Its mission is to research, develop and commercialize targeted cancer drugs with reduced toxicities compared to conventional cancer chemotherapeutics.
RSS Headlines
Fool UK
Recs
best wall street player likes it, there probably smarter than me, so im going for it.
wall street playerare you crazy.